Related Experiment Video
Updated: Mar 8, 2026

10:00
An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing
Published on: May 23, 2018
18.4K
A scalable, low-cost, sample hashing workflow for multiomic single-cell analysis using the Seq-Well S3 platform.
Daniela D Russo1,2,3,4, Sarah L Quinn2,3,4, Olha Kholod5
1Department of Immunology, Harvard Medical School, Boston, MA, USA.
Nature Protocols
|March 6, 2026
Summary
This study presents a streamlined protocol for single-cell multiomic analysis from low-input clinical samples using the Seq-Well S³ platform. The method enhances data quality and throughput while reducing costs for researchers.
Area of Science:
- Biotechnology
- Genomics
- Cell Biology
Background:
- Clinical samples offer deep insights into health, disease, and treatment responses.
- Paucicellular specimens require specialized workflows to maximize information yield.
- Existing methods for single-cell multiomics can be costly and technically demanding.
Purpose of the Study:
- To provide a detailed protocol for generating and analyzing single-cell multiomic data from low-input samples.
- To introduce a sample hashing pipeline to reduce costs and technical variation.
- To enable high-quality multiomic insights from challenging clinical specimens.
Main Methods:
- Utilizing the Seq-Well S³ platform for single-cell library generation.
- Incorporating optional antibody-oligonucleotide staining for cell surface protein quantification and multiplexing.
- Employing optional bulk RNA sequencing (SMART-seq2) for genetic demultiplexing.
- Implementing a computational pipeline for data analysis.
Main Results:
- A streamlined and efficient methodology for single-cell multiomic data generation.
- A cost-effective sample hashing strategy that reduces technical variation and increases throughput.
- High-quality multiomic data obtainable from low-input samples.
Conclusions:
- The presented protocol significantly lowers barriers to entry for researchers.
- This approach enables rapid generation of high-quality multiomic insights from clinical samples.
- The methodology is adaptable and leverages standard laboratory equipment and reagents.

